PUBLISHER: Grand View Research | PRODUCT CODE: 1633765
PUBLISHER: Grand View Research | PRODUCT CODE: 1633765
The global low GI rice market size is expected to reach USD 5.40 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 5.4% from 2025 to 2030. The growing diabetic population across the globe is a crucial factor for market growth. Moreover, shifting consumer preferences towards healthy food products for a healthy lifestyle are expected to open new opportunities for the market over the forecast period.
The Glycemic Index (GI) of rice or any food is a relative ranking based on the rise of glucose level in the blood within two hours after consuming food. The increasing prevalence of various chronic diseases, such as diabetes, cardiovascular diseases, and blood pressure, is fueling the demand for low GI rice and other food products. Moreover, fluctuating diet patterns, negligible physical activity, and junk food dependence increase the diabetic population across the globe.
Asia Pacific was the largest regional market for low GI rice, accounting for a share of more than 51.8% in 2024. The diabetic population in the region is continuously rising in some of the major economies and highly populated nations, such as India. For instance, according to the International Diabetes Federation, the global diabetes prevalence in 2019 was 9.3% (463 million people), which is likely to rise to 10.2% (578 million) by 2030 and 10.9% (700 million) by 2045. Such prevalence of the disease is propelling the demand for low GI food products, especially rice.